Use of betahistine hydrochloride in postoperative retinal detachment patients.
D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001621:Betahistine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002829:Choroid / Q000098:blood supply; D002986:Clinical Trials as Topic; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000601:surgery; D008833:Microcirculation / Q000187:drug effects; D010919:Placebos; D011182:Postoperative Care; D011725:Pyridines / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000601:surgery*; D013997:Time Factors; D014792:Visual Acuity / Q000187:drug effects
D010919:Placebos; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine